Mtb strain-dependent mechanisms of pathogenesis in mouse models
小鼠模型中 Mtb 菌株依赖性发病机制
基本信息
- 批准号:10653921
- 负责人:
- 金额:$ 43.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAerosolsAlveolar MacrophagesAnimal ModelBacillusBar CodesBehaviorCandidate Disease GeneCell CommunicationClinicalConfocal MicroscopyContainmentData SetDevelopmentDiseaseDistantDoseEventExhibitsGene Expression ProfileGenesGeneticGenetic PolymorphismGoalsGranulomaHematogenousHumanImage AnalysisImmuneImmunityIndividualInfectionInhalationInterventionKineticsLocationLungLung diseasesLung immune responseLung infectionsMacrophageMediatingMeningitisModelingModificationMolecularMusMycobacterium tuberculosisOutcomePathogenesisPathogenicityPathway interactionsPhagosomesPhysiologicalPopulationShapesSiteSortingStudy modelsSystemTestingTuberculosisVariantaerosolizedcandidate identificationcaseating granulomasclinical phenotypecohortdata integrationexperimental studyhigh riskholistic approachhuman diseasehuman modelin vivoinsightmetabolic profilemigrationmonocytemouse modelmutantneutrophilnovelpathogenpulmonary granulomaquantitative imagingresponsetraffickingtranscriptometransmission process
项目摘要
Tuberculosis (TB) is a highly heterogeneous human disease that develops in some, but not all,
individuals who inhale 1-3 infectious bacilli of Mycobacterium tuberculosis (Mtb). TB disease can
range from pulmonary disease that is mild and self-resolving, to severe, or can disseminate to
extrapulmonary sites. Understanding the complexity of TB pathogenesis requires a holistic
approach that integrates human and animal model studies. Although there is growing evidence
that Mtb strain-dependent factors drive different infection outcomes, the in vivo mechanisms that
govern these outcomes are poorly understood. In this project, we start with clinical Mtb strains
associated with different pathogenic outcomes (e.g., high transmission or disseminated disease)
or mutant strains harboring modifications in gene candidates, identified in Core A and Project
1, to identify polymorphisms in Mtb strains associated with distinct human clinical outcomes.
Mice infected with these clinical or mutant Mtb strains will be used to investigate how they
govern three distinct stages of pathogenesis: 1) establishing infection at the site of aerosol
inhalation, 2) dissemination to distant sites, and 3) interactions with host immunity in distinct
lung macrophage populations. These studies will leverage our group’s recent advances in
mouse TB models, including identifying the earliest cellular events after aerosol Mtb infection,
tracking Mtb dissemination using a physiologic, ultra low-dose (ULD) infection model in which
mice are infected with 1-3 CFUs of aerosolized Mtb, and assessing paired host and Mtb
transcriptomes in distinct pulmonary macrophage types. Multiparameter confocal microscopy
and advanced quantitative image analysis will be used to determine how these Mtb strain-
dependent factors shape immune cell interactions at infection sites. The overall goal of the
proposed experiments is to gain insight into molecular and cellular mechanisms of pathogenesis
at distinct stages of Mtb infection to inform development of novel host- and pathogen-directed
interventions.
结核病(TB)是一种高度异质性的人类疾病,在一些但不是所有人中发展,
吸入1-3支结核分枝杆菌(Mtb)感染性杆菌的个体。结核病可以
范围从轻度和自行消退的肺部疾病,到重度,或可以传播到
肺外部位。了解结核病发病机制的复杂性需要一个全面的
这是一种整合人类和动物模型研究的方法。尽管越来越多的证据表明
Mtb菌株依赖性因子驱动不同的感染结果,
对这些结果的管理知之甚少。在这个项目中,我们从临床结核菌株开始,
与不同的致病结果相关(例如,高度传播或播散性疾病)
或在核心A和项目A中鉴定的候选基因中含有修饰的突变株
1,鉴定与不同人类临床结果相关的Mtb菌株的多态性。
感染了这些临床或突变型结核分枝杆菌菌株的小鼠将用于研究它们如何在小鼠体内表达。
控制发病的三个不同阶段:1)在气溶胶部位建立感染
吸入,2)传播到远处,3)与宿主免疫的相互作用,
肺巨噬细胞群。这些研究将利用我们小组最近的进展,
小鼠TB模型,包括鉴定气溶胶Mtb感染后最早的细胞事件,
使用生理性超低剂量(ULD)感染模型跟踪Mtb传播,其中
用1- 3CFU的雾化Mtb感染小鼠,并评估配对的宿主和Mtb
转录组在不同的肺巨噬细胞类型。多参数共聚焦显微镜
先进的定量图像分析将用于确定这些结核分枝杆菌菌株-
依赖因子在感染部位形成免疫细胞相互作用。的总体目标
拟议的实验是深入了解发病机制的分子和细胞机制
在不同阶段的结核分枝杆菌感染,以告知新的主机和病原体的发展,
干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEVIN B URDAHL其他文献
KEVIN B URDAHL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEVIN B URDAHL', 18)}}的其他基金
Mtb strain-dependent mechanisms of pathogenesis in mouse models
小鼠模型中 Mtb 菌株依赖性发病机制
- 批准号:
10271174 - 财政年份:2021
- 资助金额:
$ 43.04万 - 项目类别:
Mtb strain-dependent mechanisms of pathogenesis in mouse models
小鼠模型中 Mtb 菌株依赖性发病机制
- 批准号:
10459541 - 财政年份:2021
- 资助金额:
$ 43.04万 - 项目类别:
Immune-mediated elimination of antigen-specific Tregs during infection and cancer
感染和癌症期间免疫介导的抗原特异性 Tregs 消除
- 批准号:
8692388 - 财政年份:2014
- 资助金额:
$ 43.04万 - 项目类别:
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
骨髓源性抑制细胞 (MDSC) 抑制婴儿免疫反应
- 批准号:
8640882 - 财政年份:2012
- 资助金额:
$ 43.04万 - 项目类别:
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
骨髓源性抑制细胞 (MDSC) 抑制婴儿免疫反应
- 批准号:
8830198 - 财政年份:2012
- 资助金额:
$ 43.04万 - 项目类别:
T regulatory cells and immunity in tuberculosis
结核病中的 T 调节细胞和免疫
- 批准号:
8091459 - 财政年份:2009
- 资助金额:
$ 43.04万 - 项目类别:
T regulatory cells and immunity in tuberculosis
结核病中的 T 调节细胞和免疫
- 批准号:
7654539 - 财政年份:2009
- 资助金额:
$ 43.04万 - 项目类别:
T regulatory cells and immunity in tuberculosis
结核病中的 T 调节细胞和免疫
- 批准号:
7880126 - 财政年份:2009
- 资助金额:
$ 43.04万 - 项目类别:
T regulatory cells and immunity in tuberculosis
结核病中的 T 调节细胞和免疫
- 批准号:
8121114 - 财政年份:2009
- 资助金额:
$ 43.04万 - 项目类别:
T regulatory cells and immunity in tuberculosis
结核病中的 T 调节细胞和免疫
- 批准号:
8632658 - 财政年份:2009
- 资助金额:
$ 43.04万 - 项目类别:
相似海外基金
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
- 批准号:
10092043 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
- 批准号:
2332007 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000021/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000358/1 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
- 批准号:
DP240100389 - 财政年份:2024
- 资助金额:
$ 43.04万 - 项目类别:
Discovery Projects
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
- 批准号:
2326096 - 财政年份:2023
- 资助金额:
$ 43.04万 - 项目类别:
Standard Grant
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
- 批准号:
83001507 - 财政年份:2023
- 资助金额:
$ 43.04万 - 项目类别:
Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
- 批准号:
ST/X001091/1 - 财政年份:2023
- 资助金额:
$ 43.04万 - 项目类别:
Research Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
- 批准号:
10080253 - 财政年份:2023
- 资助金额:
$ 43.04万 - 项目类别:
Small Business Research Initiative